219 related articles for article (PubMed ID: 35778998)
21. SMARCA4-Deficient Thoracic Sarcoma: A Case Report and Review of Literature.
Stewart BD; Kaye F; Machuca T; Mehta HJ; Mohammed TL; Newsom KJ; Starostik P
Int J Surg Pathol; 2020 Feb; 28(1):102-108. PubMed ID: 31382829
[TBL] [Abstract][Full Text] [Related]
22. Diagnosis of thoracic SMARCA4-deficient undifferentiated tumor in cytology.
Kezlarian B; Montecalvo J; Bodd FM; Chang JC; Riedel E; White C; Rekhtman N; Sauter JL
Cancer Cytopathol; 2023 Aug; 131(8):526-534. PubMed ID: 37278102
[TBL] [Abstract][Full Text] [Related]
23. Recent updates in thoracic SMARCA4-deficient undifferentiated tumor.
Nambirajan A; Jain D
Semin Diagn Pathol; 2021 Sep; 38(5):83-89. PubMed ID: 34147303
[TBL] [Abstract][Full Text] [Related]
24. FDG PET/CT in a Case of Thoracic SMARCA4-Deficient Undifferentiated Tumor.
Guo J; Liao Z; Chen Q; Dong A; Huang M
Clin Nucl Med; 2023 Dec; 48(12):1111-1113. PubMed ID: 37882056
[TBL] [Abstract][Full Text] [Related]
25. SMARCA4-Deficient Thoracic Sarcomatoid Tumors Represent Primarily Smoking-Related Undifferentiated Carcinomas Rather Than Primary Thoracic Sarcomas.
Rekhtman N; Montecalvo J; Chang JC; Alex D; Ptashkin RN; Ai N; Sauter JL; Kezlarian B; Jungbluth A; Desmeules P; Beras A; Bishop JA; Plodkowski AJ; Gounder MM; Schoenfeld AJ; Namakydoust A; Li BT; Rudin CM; Riely GJ; Jones DR; Ladanyi M; Travis WD
J Thorac Oncol; 2020 Feb; 15(2):231-247. PubMed ID: 31751681
[TBL] [Abstract][Full Text] [Related]
26. [Thoracic SMARCA4-deficient undifferentiated tumor resembling malignant lymphoma].
Asou C; Maeda T; Yamaguchi O; Okamura D; Ishikawa M; Kohri M; Tsukasaki K; Matsuda A; Asou N; Satoh T; Kayano H; Takahashi N
Rinsho Ketsueki; 2023; 64(4):271-276. PubMed ID: 37121771
[TBL] [Abstract][Full Text] [Related]
27. Review of SMARCA4 (BRG1)-deficient carcinomas following a malignant pleural effusion specimen confounded by reduced claudin-4 expression.
Early CA; Wangsiricharoen S; Jones RM; VandenBussche CJ
J Am Soc Cytopathol; 2021; 10(2):197-207. PubMed ID: 32893180
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of Immune Checkpoint Inhibitors in SMARCA4-Deficient Thoracic Tumor.
Shinno Y; Yoshida A; Masuda K; Matsumoto Y; Okuma Y; Yoshida T; Goto Y; Horinouchi H; Yamamoto N; Yatabe Y; Ohe Y
Clin Lung Cancer; 2022 Jul; 23(5):386-392. PubMed ID: 35618627
[TBL] [Abstract][Full Text] [Related]
29. Thoracic SMARCA4-deficient undifferentiated tumor: A clinicopathological and prognostic analysis of 35 cases and immunotherapy efficacy.
Zhou P; Fu Y; Tang Y; Jiang L; Wang W
Lung Cancer; 2024 Mar; 189():107471. PubMed ID: 38306886
[TBL] [Abstract][Full Text] [Related]
30. [SMARCA4-deficient primary thoracic sarcoma:a clinicopathological analysis of five cases].
Zheng MJ; Zheng Q; Wang Y; Shen L; Zhu XZ; Li Y
Zhonghua Bing Li Xue Za Zhi; 2019 Jul; 48(7):537-542. PubMed ID: 31288309
[No Abstract] [Full Text] [Related]
31. A Case Report of SMARCA4-Deficient Thoracic Sarcoma: A Rare and Aggressive Disease With a Grim Prognosis.
Lalaoui Rachidi S; Firmin N; Elfadli M; Essadi I; Belbaraka R
Cureus; 2023 May; 15(5):e39571. PubMed ID: 37378131
[TBL] [Abstract][Full Text] [Related]
32. SMARCA4-deficient thoracic sarcoma: report of a case and insights into how to reach the diagnosis using limited samples and resources.
Kuwamoto S; Matsushita M; Takeda K; Tanaka N; Endo Y; Yamasaki A; Kohashi K; Oda Y; Horie Y
Hum Pathol; 2017 Dec; 70():92-97. PubMed ID: 28601660
[TBL] [Abstract][Full Text] [Related]
33. Cytologic Features of SMARCA4-Deficient Thoracic Sarcoma: A Case Report and Comparison with Other SWI/SNF Complex-Deficient Tumors.
Matsushita M; Kuwamoto S
Acta Cytol; 2018; 62(5-6):456-462. PubMed ID: 30286456
[TBL] [Abstract][Full Text] [Related]
34. NUT carcinoma and thoracic SMARCA4-deficient undifferentiated tumour: facts and controversies.
Yoshida A
Histopathology; 2024 Jan; 84(1):86-101. PubMed ID: 37873676
[TBL] [Abstract][Full Text] [Related]
35. Notable response to nivolumab during the treatment of SMARCA4-deficient thoracic sarcoma: a case report.
Iijima Y; Sakakibara R; Ishizuka M; Honda T; Shirai T; Okamoto T; Tateishi T; Sakashita H; Tamaoka M; Takemoto A; Kumaki Y; Ikeda S; Miyazaki Y
Immunotherapy; 2020 Jun; 12(8):563-569. PubMed ID: 32363992
[TBL] [Abstract][Full Text] [Related]
36. SMARCA4-Deficient Undifferentiated Tumor of Lung Mass-A Rare Tumor With the Rarer Occurrence of Brain Metastasis: A Case Report and Review of the Literature.
Yadav R; Sun L; Salyana M; Eric M; Gotlieb V; Wang JC
J Investig Med High Impact Case Rep; 2022; 10():23247096221074864. PubMed ID: 35356840
[TBL] [Abstract][Full Text] [Related]
37. The golden key to open mystery boxes of SMARCA4-deficient undifferentiated thoracic tumor: focusing immunotherapy, tumor microenvironment and epigenetic regulation.
Li X; Tian S; Shi H; Ta N; Ni X; Bai C; Zhu Z; Chen Y; Shi D; Huang H; Chen L; Hu Z; Qu L; Fang Y; Bai C
Cancer Gene Ther; 2024 May; 31(5):687-697. PubMed ID: 38347129
[TBL] [Abstract][Full Text] [Related]
38. Cutaneous metastasis of SMARCA4-deficient thoracic sarcoma: A diagnostic dilemma with therapeutic implications.
Leckey BD; Selim MA; Al-Rohil RN
J Cutan Pathol; 2020 Jun; 47(6):561-565. PubMed ID: 31995235
[TBL] [Abstract][Full Text] [Related]
39. A case of radio-insensitive SMARCA4-deficient thoracic undifferentiated carcinoma with severe right heart failure.
Ito S; Asahina H; Yamaguchi N; Tomaru U; Hasegawa T; Hatanaka Y; Hatanaka KC; Taguchi H; Harada T; Ohira H; Ikeda D; Mizugaki H; Kikuchi E; Kikuchi J; Sakakibara-Konishi J; Shinagawa N; Konno S
Respir Med Case Rep; 2021; 32():101364. PubMed ID: 33665078
[TBL] [Abstract][Full Text] [Related]
40. Chemotherapy and Immune Checkpoint Inhibitors in a Case of SMARCA4-dUT: A Case Report and Review of Literature.
Pokhrel A; Yadav R; Manvar KK; Wu R; Jaswani V; Wasserman CB; Wang JC
J Investig Med High Impact Case Rep; 2023; 11():23247096231176220. PubMed ID: 37269109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
